1.295USD-4.07%Mkt Cap: 106.96M USDP/E: —Last update: 2026-05-26
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), c…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap106.96M USD
Enterprise Value80.44M USD
Revenue (TTM)0 USD
Gross Profit-54.21M USD
Net Income (TTM)-84.95M USD
Revenue/Share0.0000 USD
Last Price1.295 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees112
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45773H2013
Valuation
P/E (Trailing)—
P/E (Forward)-2.36
PEG—
EV/EBITDA-0.98
EV/Revenue—
P/SInfinity
P/B3.81
EPS (TTM)-1.58
EPS (Forward)-0.56
52W Range
1.03014% of range2.980
52W High2.980 USD
52W Low1.030 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-130000.00%
ROE-352.53%
ROA-114.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-88.63M USD
CapEx (TTM)285.70K USD
FCF Margin—
FCF Yield-31.57%
Net Debt-28.99M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.39
Current Ratio1.04
Quick Ratio0.99
Book Value/Sh0.3490 USD
Cash/Share0.4580 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJan 25, 2024
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)5.960 USD
Target Range1.800 USD – 13.00 USD
# Analysts5
Ownership
Shares Out.82.27M
Float81.93M
Insiders0.39%
Institutions47.26%
Short Interest
Short Ratio5.0d
Short % Float19.94%
Short % Out.17.45%
Shares Short14.24M
Short (prev mo.)9.88M
Technical
SMA 501.328 (-2.5%)
SMA 2001.854 (-30.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)3.42M
Avg Vol (10d)5.61M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—